Epidemiology and Clinical Outcomes of Non-HACEK Gram-Negative Infective Endocarditis
Abstract Background The objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors associated with treatment failure and death. Methods Adult patients with GNIE were included if they met modified Duke criteria for defini...
Saved in:
Published in | Open forum infectious diseases Vol. 10; no. 3; p. ofad052 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
US
Oxford University Press
01.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Background
The objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors associated with treatment failure and death.
Methods
Adult patients with GNIE were included if they met modified Duke criteria for definitive infective endocarditis (IE) between April 2010 and December 2021. Patients were identified using Boolean search terms. Clinical failure was a defined as a composite of all-cause 42-day mortality or microbiologic failure. All analyses were performed using Stata, version 15.1.
Results
One-hundred twenty-three patients were included. The most common pathogens were Serratia spp. (43%), Pseudomonas aeruginosa (21%), and Klebsiella spp. (14%). Fifty-two percent of cases were among persons who injection drugs (PWID; n = 64), for whom Serratia spp. (70%) was the most common cause of GNIE. Overall, patients infected with P. aeruginosa had higher microbiologic failure rates than other patients (23% vs 6%; P = .004). Patients who received combination therapy (n = 53) had comparable median lengths of stay (23 vs 19.5 days; P = .412), microbiologic failure rates (11.3% vs 7.1%; P = .528), clinical failure rates (18.9% vs 22.9%; P = .592), and 90-day mortality rates (13.2% vs 25.7%; P = .088) as those treated with monotherapy. After applying stepwise logistic regression, male gender, Pitt Bacteremia Score, and not receiving surgical intervention despite a surgical indication were associated with clinical failure.
Conclusions
This is the first study to identify Serratia spp. as the most common etiology of GNIE, which was particularly true among PWID. Microbiologic failures occurred most commonly among P. aeruginosa, and use of combination antimicrobial therapy did not improve clinical outcomes. |
---|---|
AbstractList | Abstract
Background
The objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors associated with treatment failure and death.
Methods
Adult patients with GNIE were included if they met modified Duke criteria for definitive infective endocarditis (IE) between April 2010 and December 2021. Patients were identified using Boolean search terms. Clinical failure was a defined as a composite of all-cause 42-day mortality or microbiologic failure. All analyses were performed using Stata, version 15.1.
Results
One-hundred twenty-three patients were included. The most common pathogens were Serratia spp. (43%), Pseudomonas aeruginosa (21%), and Klebsiella spp. (14%). Fifty-two percent of cases were among persons who injection drugs (PWID; n = 64), for whom Serratia spp. (70%) was the most common cause of GNIE. Overall, patients infected with P. aeruginosa had higher microbiologic failure rates than other patients (23% vs 6%; P = .004). Patients who received combination therapy (n = 53) had comparable median lengths of stay (23 vs 19.5 days; P = .412), microbiologic failure rates (11.3% vs 7.1%; P = .528), clinical failure rates (18.9% vs 22.9%; P = .592), and 90-day mortality rates (13.2% vs 25.7%; P = .088) as those treated with monotherapy. After applying stepwise logistic regression, male gender, Pitt Bacteremia Score, and not receiving surgical intervention despite a surgical indication were associated with clinical failure.
Conclusions
This is the first study to identify Serratia spp. as the most common etiology of GNIE, which was particularly true among PWID. Microbiologic failures occurred most commonly among P. aeruginosa, and use of combination antimicrobial therapy did not improve clinical outcomes. BackgroundThe objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors associated with treatment failure and death. MethodsAdult patients with GNIE were included if they met modified Duke criteria for definitive infective endocarditis (IE) between April 2010 and December 2021. Patients were identified using Boolean search terms. Clinical failure was a defined as a composite of all-cause 42-day mortality or microbiologic failure. All analyses were performed using Stata, version 15.1. ResultsOne-hundred twenty-three patients were included. The most common pathogens were Serratia spp. (43%), Pseudomonas aeruginosa (21%), and Klebsiella spp. (14%). Fifty-two percent of cases were among persons who injection drugs (PWID; n = 64), for whom Serratia spp. (70%) was the most common cause of GNIE. Overall, patients infected with P. aeruginosa had higher microbiologic failure rates than other patients (23% vs 6%; P = .004). Patients who received combination therapy (n = 53) had comparable median lengths of stay (23 vs 19.5 days; P = .412), microbiologic failure rates (11.3% vs 7.1%; P = .528), clinical failure rates (18.9% vs 22.9%; P = .592), and 90-day mortality rates (13.2% vs 25.7%; P = .088) as those treated with monotherapy. After applying stepwise logistic regression, male gender, Pitt Bacteremia Score, and not receiving surgical intervention despite a surgical indication were associated with clinical failure. ConclusionsThis is the first study to identify Serratia spp. as the most common etiology of GNIE, which was particularly true among PWID. Microbiologic failures occurred most commonly among P. aeruginosa, and use of combination antimicrobial therapy did not improve clinical outcomes. The objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors associated with treatment failure and death. Adult patients with GNIE were included if they met modified Duke criteria for definitive infective endocarditis (IE) between April 2010 and December 2021. Patients were identified using Boolean search terms. Clinical failure was a defined as a composite of all-cause 42-day mortality or microbiologic failure. All analyses were performed using Stata, version 15.1. One-hundred twenty-three patients were included. The most common pathogens were spp. (43%), (21%), and spp. (14%). Fifty-two percent of cases were among persons who injection drugs (PWID; n = 64), for whom spp. (70%) was the most common cause of GNIE. Overall, patients infected with had higher microbiologic failure rates than other patients (23% vs 6%; = .004). Patients who received combination therapy (n = 53) had comparable median lengths of stay (23 vs 19.5 days; = .412), microbiologic failure rates (11.3% vs 7.1%; = .528), clinical failure rates (18.9% vs 22.9%; = .592), and 90-day mortality rates (13.2% vs 25.7%; = .088) as those treated with monotherapy. After applying stepwise logistic regression, male gender, Pitt Bacteremia Score, and not receiving surgical intervention despite a surgical indication were associated with clinical failure. This is the first study to identify spp. as the most common etiology of GNIE, which was particularly true among PWID. Microbiologic failures occurred most commonly among , and use of combination antimicrobial therapy did not improve clinical outcomes. |
Author | Clarke, Lloyd G Shah, Sunish Shields, Ryan K |
Author_xml | – sequence: 1 givenname: Sunish orcidid: 0000-0002-8873-1451 surname: Shah fullname: Shah, Sunish email: sunishshah93@gmail.com – sequence: 2 givenname: Lloyd G surname: Clarke fullname: Clarke, Lloyd G – sequence: 3 givenname: Ryan K orcidid: 0000-0001-9794-5665 surname: Shields fullname: Shields, Ryan K email: shieldsrk@upmc.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36968963$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kbtPwzAQxi0E4r0xo2wwELDjuI4nhKJSEFVZYLYufhSjxA5xgsR_T6ClgoXlHrqfvjvdd4C2ffAGoROCLwkW9CpYp8cAGrNsC-1nNCvSQjC-_aveQ8cxvmKMCcEMc7GL9uhETAoxofvoado6bRoX6rD8SMDrpKyddwrq5HHoVWhMTIJNFsGndzfl9CGZddCkC7OE3r2b5N5bo76rqddBQadd7-IR2rFQR3O8zofo-Xb6VN6l88fZfXkzT1Ve5H1qCaPYWFIpoQqutGWUZMyOLWYaBAeSU2Yxq0RmqkJlhuc5UFACRAG8EvQQXa9026FqjFbG9x3Usu1cA92HDODk34l3L3IZ3iXBmOZMZKPC-VqhC2-Dib1sXFSmrsGbMESZcUE4ZpzREb1YoaoLMXbGbvYQLL_MkF9myLUZI376-7YN_PP6EThbAWFo_5f6BGA7lvE |
CitedBy_id | crossref_primary_10_1093_jac_dkae205 crossref_primary_10_3390_tropicalmed8050283 crossref_primary_10_1093_jac_dkad254 crossref_primary_10_1007_s15010_024_02311_z crossref_primary_10_24969_hvt_2024_460 |
Cites_doi | 10.1097/IPC.0000000000000834 10.7326/0003-4819-147-12-200712180-00002 10.1161/CIR.0000000000000296 10.1007/s00392-020-01686-x 10.4081/monaldi.2020.1359 10.1128/AAC.02208-17 10.1097/MD.0b013e3181b8bedc 10.1371/journal.pone.0230199 10.1128/AAC.00925-21 10.1093/ofid/ofab102 10.1086/313753 10.1016/j.ejim.2021.04.021 10.1093/eurheartj/ehv319 10.1001/archinte.1980.00330140057018 10.7326/0003-4819-84-1-29 10.1097/IPC.0000000000000614 10.1111/j.1469-0691.2011.03570.x |
ContentType | Journal Article |
Copyright | The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2023 The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. |
Copyright_xml | – notice: The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2023 – notice: The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. |
DBID | TOX NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1093/ofid/ofad052 |
DatabaseName | Oxford Open (Open Access) PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: TOX name: Oxford Journals Open Access Collection url: https://academic.oup.com/journals/ sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2328-8957 |
EndPage | ofad052 |
ExternalDocumentID | 10_1093_ofid_ofad052 36968963 10.1093/ofid/ofad052 |
Genre | Journal Article |
GroupedDBID | 0R~ 53G 5VS AAFWJ AAMVS AAPPN AAPXW AAVAP ABDBF ABPTD ABXVV ACGFS ADBBV ADHZD ADPDF ADRAZ AENZO AFPKN AFULF ALMA_UNASSIGNED_HOLDINGS ALUQC AOIJS BAWUL BAYMD BCNDV BTTYL CIDKT DIK EBS EJD GROUPED_DOAJ H13 HYE IAO KQ8 KSI M48 M~E O9- OAWHX OJQWA OK1 OVD OVEED PEELM ROL ROX RPM TEORI TJX TOX ITC NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c484t-f1530ef1bc9c87cdf53125fbc905da97a1435f05b92eb8c2e744a3ac9a98a7b93 |
IEDL.DBID | RPM |
ISSN | 2328-8957 |
IngestDate | Tue Sep 17 21:31:48 EDT 2024 Sat Oct 05 05:47:36 EDT 2024 Thu Sep 26 18:20:45 EDT 2024 Sat Sep 28 08:17:24 EDT 2024 Wed Aug 28 03:17:33 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | IVDA endocarditis gram-negative PWID Serratia |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c484t-f1530ef1bc9c87cdf53125fbc905da97a1435f05b92eb8c2e744a3ac9a98a7b93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Potential conflicts of interest. No funding sources were received for this study. R.K.S. has served as a consultant for Allergan, Cidara, Shionogi, Menarini, Melinta, Merck, Entasis, Utility, and Venatorx and has received investigator-initiated funding from Merck, Melinta, Shionogi, and Venatorx. All other authors report no potential conflicts. |
ORCID | 0000-0001-9794-5665 0000-0002-8873-1451 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034592/ |
PMID | 36968963 |
PQID | 2791705753 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10034592 proquest_miscellaneous_2791705753 crossref_primary_10_1093_ofid_ofad052 pubmed_primary_36968963 oup_primary_10_1093_ofid_ofad052 |
PublicationCentury | 2000 |
PublicationDate | 2023-03-01 |
PublicationDateYYYYMMDD | 2023-03-01 |
PublicationDate_xml | – month: 03 year: 2023 text: 2023-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | US |
PublicationPlace_xml | – name: US – name: United States |
PublicationTitle | Open forum infectious diseases |
PublicationTitleAlternate | Open Forum Infect Dis |
PublicationYear | 2023 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Mills (2023032309161621400_) 1976; 84 Calderón Parra (2023032309161621400_) 2021; 92 El-Dalati (2023032309161621400_) 2020; 28 Kelly (2023032309161621400_) 2021; 65 Veve (2023032309161621400_) 2020; 15 Van Camp (2023032309161621400_) 2020; 109 Thomas (2023032309161621400_) 2020; 90 Morpeth (2023032309161621400_) 2007; 147 Baddour (2023032309161621400_) 2015; 132 Reyes (2023032309161621400_) 2009; 88 Shah (2023032309161621400_) 2021; 8 Cooper (2023032309161621400_) 1980; 140 Substance Abuse and Mental Health Services Administration (2023032309161621400_) 2021 Falcone (2023032309161621400_) 2018; 62 Magiorakos (2023032309161621400_) 2012; 18 Habib (2023032309161621400_) 2015; 36 Li (2023032309161621400_) 2000; 30 Von pycocyaneus-sptikamie mit komplizierender (2023032309161621400_) 1899; 25 Schechter (2023032309161621400_) 2018; 26 |
References_xml | – volume: 28 start-page: 138 year: 2020 ident: 2023032309161621400_ article-title: The clinical impact of 16S ribosomal RNA polymerase chain reaction bacterial sequencing in infectious endocarditis: a single center experience publication-title: Infect Dis Clin Pract doi: 10.1097/IPC.0000000000000834 contributor: fullname: El-Dalati – volume: 25 start-page: 113 year: 1899 ident: 2023032309161621400_ article-title: Pyocyaneous endocarditis in kindesalter publication-title: Centrlabl f Bakt contributor: fullname: Von pycocyaneus-sptikamie mit komplizierender – volume: 147 start-page: 829 year: 2007 ident: 2023032309161621400_ article-title: Non-HACEK gram-negative Bacillus endocarditis publication-title: Ann Intern Med doi: 10.7326/0003-4819-147-12-200712180-00002 contributor: fullname: Morpeth – year: 2021 ident: 2023032309161621400_ contributor: fullname: Substance Abuse and Mental Health Services Administration – volume: 132 start-page: 1435 year: 2015 ident: 2023032309161621400_ article-title: Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association publication-title: Circulation doi: 10.1161/CIR.0000000000000296 contributor: fullname: Baddour – volume: 109 start-page: 1573 year: 2020 ident: 2023032309161621400_ article-title: Disturbing effect of lockdown for COVID-19 on the incidence of infective endocarditis: a word of caution publication-title: Clin Res Cardiol doi: 10.1007/s00392-020-01686-x contributor: fullname: Van Camp – volume: 90 start-page: 614 year: 2020 ident: 2023032309161621400_ article-title: Gram-negative infective endocarditis: a retrospective analysis of 10 years data on clinical spectrum, risk factor and outcome publication-title: Monaldi Arch Chest Dis doi: 10.4081/monaldi.2020.1359 contributor: fullname: Thomas – volume: 62 start-page: e02208 year: 2018 ident: 2023032309161621400_ article-title: Risk factors and outcomes of endocarditis due to non-HACEK gram-negative bacilli: data from the prospective multicenter Italian endocarditis study cohort publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02208-17 contributor: fullname: Falcone – volume: 88 start-page: 294 year: 2009 ident: 2023032309161621400_ article-title: Resurgence of Pseudomonas endocarditis in Detroit, 2006–2008 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0b013e3181b8bedc contributor: fullname: Reyes – volume: 15 year: 2020 ident: 2023032309161621400_ article-title: Epidemiology and outcomes of non-HACEK infective endocarditis in the Southeast United States publication-title: PLoS One doi: 10.1371/journal.pone.0230199 contributor: fullname: Veve – volume: 65 year: 2021 ident: 2023032309161621400_ article-title: Incidence and predictors of gram-negative bacilli in hospitalized people who inject drugs with injection drug use-attributable infections publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00925-21 contributor: fullname: Kelly – volume: 8 year: 2021 ident: 2023032309161621400_ article-title: Ampicillin-ceftriaxone vs ampicillin-gentamicin for definitive therapy of Enterococcus faecalis infective endocarditis: a propensity score-matched, retrospective cohort analysis publication-title: Open Forum Infect Dis doi: 10.1093/ofid/ofab102 contributor: fullname: Shah – volume: 30 start-page: 633 year: 2000 ident: 2023032309161621400_ article-title: Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis publication-title: Clin Infect Dis doi: 10.1086/313753 contributor: fullname: Li – volume: 92 start-page: 71 year: 2021 ident: 2023032309161621400_ article-title: Non-HACEK gram negative bacilli endocarditis: analysis of a national prospective cohort publication-title: Eur J Intern Med doi: 10.1016/j.ejim.2021.04.021 contributor: fullname: Calderón Parra – volume: 36 start-page: 3075 year: 2015 ident: 2023032309161621400_ article-title: 2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv319 contributor: fullname: Habib – volume: 140 start-page: 199 year: 1980 ident: 2023032309161621400_ article-title: Serratia endocarditis. A follow-up report publication-title: Arch Intern Med doi: 10.1001/archinte.1980.00330140057018 contributor: fullname: Cooper – volume: 84 start-page: 29 year: 1976 ident: 2023032309161621400_ article-title: Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse publication-title: Ann Intern Med doi: 10.7326/0003-4819-84-1-29 contributor: fullname: Mills – volume: 26 start-page: 216 year: 2018 ident: 2023032309161621400_ article-title: Serratia marcescens infectious endocarditis publication-title: Infect Dis Clin Pract doi: 10.1097/IPC.0000000000000614 contributor: fullname: Schechter – volume: 18 start-page: 268 year: 2012 ident: 2023032309161621400_ article-title: Multidrug-resistant, extensively drug-resistant and pandrugresistant bacteria: an international expert proposal for interim standard definitions for acquired resistance publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2011.03570.x contributor: fullname: Magiorakos |
SSID | ssj0001105079 |
Score | 2.329947 |
Snippet | Abstract
Background
The objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify... The objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors associated with... BackgroundThe objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors... |
SourceID | pubmedcentral proquest crossref pubmed oup |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | ofad052 |
SubjectTerms | Major |
SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bS8MwFA5jgvgi3p03IuhjtOtlTR5ExticyubLBnsrSZPoYHa6duD-vSdtNrch7KW0NGnLOSfJl-bk-xC68agAUMFjokMhiF8Na4RRVxNqJFSZBoQUm_3OnW6t3fdfBsGghOZqo9aA6b9TO6Mn1Z-M7n6-Z4_Q4B8sGdI9eEHCgUsngM54yzWUXCaJzwL9_G8LwAgnZDbzfb3Sypi0ss9tCW6uZ00uDUOtPbRr8SOuFw7fRyWVHKDtjl0hP0S95p_k6wzzRGLL_DnCb9MMwkuleKxxd5yQdr3RfMVPE_5Juuo9JwDHz0VuFpw1EwnDHIRPNkyPUL_V7DXaxConkNinfkY09GOO0lURs5iGsdTQ0txAw6UTSM5CblCSdgLBXCVo7KrQ97nHY8YZ5aFg3jEqJ-NEnSLMBFeOlFUKr_epdKCyBlTBBXVqSrphBd3ObRd9FQQZUbGw7UXGxpG1cQVhMOyGItdzq0cQ5GblgidqPE0jCBtD-wNTqwo6KbyweJIRJKTQjVQQXfHPooAh0F69kww_ciLtqmHnCZh7tvnbztGOEZovss8uUDmbTNUlwJFMXOWR9guukeMZ priority: 102 providerName: Scholars Portal |
Title | Epidemiology and Clinical Outcomes of Non-HACEK Gram-Negative Infective Endocarditis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36968963 https://search.proquest.com/docview/2791705753 https://pubmed.ncbi.nlm.nih.gov/PMC10034592 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwED5BB8SCeFNeMhKMpmmaNPaIqpYCamEoUrfIT6hEXUTTgX_POQ9oWZBYrESxk-j8xf4uPn8HcNliEkmFUNQmUtKombQpZ6GlzKdQ5RYZkvL7nQfDdv85uh_H4zVoV3th8qB9JSfX7m167SaveWzl-1Q1qjixxtOg0_SqKjEPG-uwjghd8tHzPytIGYKEl1Hu6LE3sJs0FkIHcbgy_6zsaVuilr8jJJemnN42bJVckdwU77QDa8btwsagXA3fg1H3J73rJxFOk1Ll8408LjKEkpmTmSXDmaP9m073gdx-iCkdmpdc7JvcFXFYeNR1Gqc0hEo2me_Dc6876vRpmSWBqohFGbU4ZgXGNqXiiiVKW_yqwtjiaRBrwRPhGZENYslDI5kKTRJFoiUUF5yJRPLWAdTczJkjIFwKE2jdZPj4iOkAG1tkEEKyoG10mNThqrJd-l6IYaTFInYr9TZOSxvXgaBh_6hyUVk9RUD7VQrhzGwxTxEiXuIH3ag6HBa98H0nn3yQ4ZBRB7bSP98VvFj26hXEUC6aXWHm-P9NT2DTJ5svItBOoZZ9LMwZUpJMnueuPJaDiJ3naMRy9Dj-As9d6Ls |
link.rule.ids | 230,315,730,783,787,867,888,1607,2228,24332,27938,27939,53806,53808 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JTxsxGP3EIpVeCi1L01JwJTg6mUxmMvYRRaFhSdpDENxGXtuIxEFkcii_ns-zQMIFwWU0I9uz6Hl5Hj-_D-CoxSSSCqGoTaSkUTNpU85CS5kPocotMiTl9zv3B-3eVXR-E9-sQLvaC5OL9pUc1d14Unejf7m28m6iGpVOrPGn32l6V5WYh41VWMcGG7QXZun5vxUkDUHCS507ztkbCJTGg9BBHC6NQEu72hbI5UuN5MKgc7oJ19XrFlqT2_o8k3X18MLJ8e3fswWfSh5KTor0z7Bi3Bf40C9X2rdh2H0OHfufCKdJ6SA6Jr_nGVZTMyNTSwZTR3snne4F-XUvJnRg_uZG4uSs0HjhWddpHC6xGmaj2Q5cnXaHnR4tIzBQFbEooxb7w8DYplRcsURpiy02jC1eBrEWPBGebdkgljw0kqnQJFEkWkJxwZlIJG_twpqbOvMVCJfCBFo3GT4-YjrAwhbZiZAIn9FhUoPjCpX0rjDaSIsF8lbq0UtL9GpAELJXsvys8EyxsfgVEOHMdD5Lsfp5-yCcotVgr8D36U4-sCHD7qgGbAn5pwzeiHs5BfHMDbkr_L69v-ghbPSG_cv08mxw8R0--qD2hdJtH9ay-7n5gdQnkwd5PX8EYPUIAA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bT9swGP3EQEJ7GWMX1l3Ak7ZHN26aNPYj6lrKWDseQELaQ-QrVKNuRdMH9uv3ORfW8jKJlyhR7Fx0PsfH8fH5AL50uUJSITV1mVI06WQ9KnjsKA8pVIVDhqTDeufxpDe6TL5fpVe1qnJZyyq9VtO2v521_fSm1FYuZjpqdGLR-bjfCa4qqYijhXHRM9jBRsv42ki9_L-CxIFlota647g9QrAMbqRhabzRC22sbFsjmI91kmsdz3APfjWPXOlNfrdXhWrrP4_cHJ_2Ti_hRc1HyXFVZh-2rH8Fu-N6xv01XAz-pZC9J9IbUjuJ3pKfqwLD1S7J3JHJ3NPRcX9wRk7u5IxO7HVpKE5OK60X7g28wW4Tw7GYLt_A5XBw0R_ROhMD1QlPCurwu8is6ygtNM-0cdhy49ThIUuNFJkMrMuxVInYKq5jmyWJ7EotpOAyU6L7Frb93Nt3QISSlhnT4Xj7hBuGlR2yFKk461kTZy342iCTLyrDjbyaKO_mAcG8RrAFBGH7T5HPDaY5NpowEyK9na-WOYZhsBHCoVoLDiqMH64UEhxy_Cy1gG-g_1AgGHJvnkFMS2PuBsP3T696BLvn34b5j9PJ2Qd4HnLbV4K3j7Bd3K3sJ2RAhTosQ_0vkhsKgA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+and+Clinical+Outcomes+of+Non-HACEK+Gram-Negative+Infective+Endocarditis&rft.jtitle=Open+forum+infectious+diseases&rft.au=Shah%2C+Sunish&rft.au=Clarke%2C+Lloyd+G&rft.au=Shields%2C+Ryan+K&rft.date=2023-03-01&rft.pub=Oxford+University+Press&rft.eissn=2328-8957&rft.volume=10&rft.issue=3&rft_id=info:doi/10.1093%2Fofid%2Fofad052&rft.externalDocID=10.1093%2Fofid%2Fofad052 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2328-8957&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2328-8957&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2328-8957&client=summon |